CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response

Stem Cell Research

Volumn 23, Issue , 2017, Pages 77-86

  Ceholski, Delaine K ^a   Turnbull, Irene C ^a   Pothula, Venu ^a   Lecce, Laura ^a   Jarrah, Andrew A ^a   Kho, Changwon ^a   Lee, Ahyoung ^a   Hadri, Lahouaria ^a   Costa, Kevin D ^a   Hajjar, Roger J ^a   Tarzami, Sima T ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiogenesis; CXCR4; CXCR7; Engineered tissue; hiPSC

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; LENTIVIRUS VECTOR; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR SOX2; BETA ADRENERGIC RECEPTOR; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR; CXCR4 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADRENERGIC SYSTEM; ALPHAMYHC GENE; ANF GENE; ARTICLE; BETAMYHC GENE; CALCIUM TRANSPORT; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SPECIFICITY; CHRONOTROPISM; CONTROLLED STUDY; FLOW CYTOMETRY; FORCE; GENE EXPRESSION; GENE SILENCING; HEART TISSUE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INDUCED PLURIPOTENT STEM CELL; MARKER GENE; OCT4 GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOX2 GENE; TISSUE ENGINEERING; TNNT2 GENE; CARDIAC MUSCLE; CARDIOMEGALY; CYTOLOGY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN; HEK293 CELL LINE; LENTIVIRUS; METABOLISM; ORGANOGENESIS; PATHOLOGY;

BIOMARKERS; CALCIUM; CARDIOMEGALY; CELL LINEAGE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; MYOCARDIUM; MYOCYTES, CARDIAC; ORGANOGENESIS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, CXCR; RECEPTORS, CXCR4; RNA, SMALL INTERFERING;

EID: 85023609571     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2017.06.015     Document Type: Article

References (37)

1. Balabanian, K., Lagane, B., Infantino, S., Chow, K.Y., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., Bachelerie, F., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280:42 (2005), 35760–35766, 10.1074/jbc.M508234200.
2. Beloussov, L.V., Dorfman, J.G., Cherdantzev, V.G., Mechanical stresses and morphological patterns in amphibian embryos. J. Embryol. Exp. Morphol. 34:3 (1975), 559–574.
3. Bers, D.M., Calcium fluxes involved in control of cardiac myocyte contraction. Circ. Res. 87:4 (2000), 275–281.
4. Bhattacharya, S., Burridge, P.W., Kropp, E.M., Chuppa, S.L., Kwok, W.M., Wu, J.C., Boheler, K.R., Gundry, R.L., High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. J. Vis. Exp., 91, 2014, 52010, 10.3791/52010.
5. Burridge, P.W., Matsa, E., Shukla, P., Lin, Z.C., Churko, J.M., Ebert, A.D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N.M., Plews, J.R., Abilez, O.J., Cui, B., Gold, J.D., Wu, J.C., Chemically defined generation of human cardiomyocytes. Nat. Methods 11:8 (2014), 855–860, 10.1038/nmeth.2999.
6. Busillo, J.M., Benovic, J.L., Regulation of CXCR4 signaling. Biochim. Biophys. Acta 1768:4 (2007), 952–963 DOI: S0005-2736(06)00421-4 [pii] 10.1016/j.bbamem.2006.11.002.
7. Chiriac, A., Terzic, A., Park, S., Ikeda, Y., Faustino, R., Nelson, T.J., SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells. J. Cardiovasc. Transl. Res. 3:6 (2010), 674–682, 10.1007/s12265-010-9219-1.
8. Decaillot, F.M., Kazmi, M.A., Lin, Y., Ray-Saha, S., Sakmar, T.P., Sachdev, P., CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J. Biol. Chem. 286:37 (2011), 32188–32197, 10.1074/jbc.M111.277038.
9. Galende, E., Karakikes, I., Edelmann, L., Desnick, R.J., Kerenyi, T., Khoueiry, G., Lafferty, J., McGinn, J.T., Brodman, M., Fuster, V., Hajjar, R.J., Polgar, K., Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram 12:2 (2010), 117–125, 10.1089/cell.2009.0077.
10. Gerrits, H., van Ingen Schenau, D.S., Bakker, N.E., van Disseldorp, A.J., Strik, A., Hermens, L.S., Koenen, T.B., Krajnc-Franken, M.A., Gossen, J.A., Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Genesis 46:5 (2008), 235–245.
11. Karakikes, I., Senyei, G.D., Hansen, J., Kong, C.W., Azeloglu, E.U., Stillitano, F., Lieu, D.K., Wang, J., Ren, L., Hulot, J.S., Iyengar, R., Li, R.A., Hajjar, R.J., Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells Transl. Med. 3:1 (2014), 18–31, 10.5966/sctm.2013-0110.
12. Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B., Gomori, J.M., Kassis, I., Bulte, J.W., Petrou, P., Ben-Hur, T., Abramsky, O., Slavin, S., Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67:10 (2010), 1187–1194, 10.1001/archneurol.2010.248.
13. Keller, R., Davidson, L.A., Shook, D.R., How we are shaped: the biomechanics of gastrulation. Differentiation 71:3 (2003), 171–205, 10.1046/j.1432-0436.2003.710301.x.
14. Larocca, T.J., Jeong, D., Kohlbrenner, E., Lee, A., Chen, J., Hajjar, R.J., Tarzami, S.T., CXCR4 gene transfer prevents pressure overload induced heart failure. J. Mol. Cell. Cardiol. 53:2 (2012), 223–232, 10.1016/j.yjmcc.2012.05.016.
15. LaRocca, T.J., Schwarzkopf, M., Altman, P., Zhang, S., Gupta, A., Gomes, I., Alvin, Z., Champion, H.C., Haddad, G., Hajjar, R.J., Devi, L.A., Schecter, A.D., Tarzami, S.T., beta2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. J. Cardiovasc. Pharmacol. 56:5 (2010), 548–559, 10.1097/FJC.0b013e3181f713fe.
16. Le, T., Chong, J., Cardiac progenitor cells for heart repair. Cell Death Discov., 2, 2016, 16052, 10.1038/cddiscovery.2016.52.
17. Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., Lagane, B., CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113:24 (2009), 6085–6093, 10.1182/blood-2008-12-196618.
18. Lipfert, J., Odemis, V., Engele, J., Grk2 is an essential regulator of CXCR7 signalling in astrocytes. Cell. Mol. Neurobiol. 33:1 (2013), 111–118, 10.1007/s10571-012-9876-5.
19. Ludwig, T.E., Bergendahl, V., Levenstein, M.E., Yu, J., Probasco, M.D., Thomson, J.A., Feeder-independent culture of human embryonic stem cells. Nat. Methods 3:8 (2006), 637–646, 10.1038/nmeth902.
20. Ma, Q., Jones, D., Borghesani, P.R., Segal, R.A., Nagasawa, T., Kishimoto, T., Bronson, R.T., Springer, T.A., Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95:16 (1998), 9448–9453.
21. Matsumoto, S., Islet cell transplantation for Type 1 diabetes. J. Diabetes 2:1 (2010), 16–22, 10.1111/j.1753-0407.2009.00048.x.
22. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H., Kishimoto, T., Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:6592 (1996), 635–638, 10.1038/382635a0.
23. Neel, N.F., Schutyser, E., Sai, J., Fan, G.H., Richmond, A., Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev. 16:6 (2005), 637–658, 10.1016/j.cytogfr.2005.05.008.
24. Nelson, T.J., Faustino, R.S., Chiriac, A., Crespo-Diaz, R., Behfar, A., Terzic, A., CXCR4 +/FLK-1 + biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells 26:6 (2008), 1464–1473, 10.1634/stemcells.2007-0808.
25. Penn, M.S., Mendelsohn, F.O., Schaer, G.L., Sherman, W., Farr, M., Pastore, J., Rouy, D., Clemens, R., Aras, R., Losordo, D.W., An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ. Res. 112:5 (2013), 816–825, 10.1161/CIRCRESAHA.111.300440.
26. Persons, D.A., The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in beta-thalassemia patients. Ann. N. Y. Acad. Sci. 1202 (2010), 69–74, 10.1111/j.1749-6632.2010.05581.x.
27. Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C.M., Gerard, N.P., Gerard, C., Lefkowitz, R.J., Beta-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7. Proc. Natl. Acad. Sci. U. S. A. 107:2 (2010), 628–632, 10.1073/pnas.0912852107.
28. Robertson, C., Tran, D.D., George, S.C., Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 31:5 (2013), 829–837, 10.1002/stem.1331.
29. Sanchez-Alcaniz, J.A., Haege, S., Mueller, W., Pla, R., Mackay, F., Schulz, S., Lopez-Bendito, G., Stumm, R., Marin, O., Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69:1 (2011), 77–90, 10.1016/j.neuron.2010.12.006.
30. Serrao, G.W., Turnbull, I.C., Ancukiewicz, D., Kim do, E., Kao, E., Cashman, T.J., Hadri, L., Hajjar, R.J., Costa, K.D., Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells. Tissue Eng. Part A 18:13–14 (2012), 1322–1333, 10.1089/ten.TEA.2011.0278.
31. Springael, J.Y., Urizar, E., Parmentier, M., Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev. 16:6 (2005), 611–623, 10.1016/j.cytogfr.2005.05.005.
32. Szodoray, P., Varoczy, L., Szegedi, G., Zeher, M., Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. Scand. J. Rheumatol. 39:1 (2010), 1–11, 10.3109/03009740903030324.
33. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:4 (2006), 663–676, 10.1016/j.cell.2006.07.024.
34. Trounson, A., Thakar, R.G., Lomax, G., Gibbons, D., Clinical trials for stem cell therapies. BMC Med., 9, 2011, 52, 10.1186/1741-7015-9-52.
35. Uto-Konomi, A., McKibben, B., Wirtz, J., Sato, Y., Takano, A., Nanki, T., Suzuki, S., CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4. Biochem. Biophys. Res. Commun. 431:4 (2013), 772–776, 10.1016/j.bbrc.2013.01.032.
36. Wang, E.R., Jarrah, A.A., Benard, L., Chen, J., Schwarzkopf, M., Hadri, L., Tarzami, S.T., Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administration. Gene Ther. 21:5 (2014), 496–506, 10.1038/gt.2014.23.
37. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I., Littman, D.R., Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:6685 (1998), 595–599.